Liangbin Lin

2.3k citations
12 papers · 1.6k indexed · 1 hit paper · h-index 6
Topics
Immune Cell Function and Interaction (4 papers)interferon and immune responses (3 papers)Immunotherapy and Immune Responses (3 papers)

In The Last Decade

Liangbin Lin

10 papers receiving 1.6k citations

Hit Papers

Targeting NF-κB pathway for the therapy of diseases: mech...202020262022202420204008001.2k

Peers

Liangbin Lin
Comparison fields: 5 of 107
  • Molecular Biology 749
  • Immunology 573
  • Cancer Research 309
  • Oncology 230
  • Epidemiology 131
Replace Siamak Sandoghchian Shotorbani with:
Siamak Sandoghchian Shotorbani Iran
Ying Nie China
Xiaoyi Hu China
Zhe Jian China
Li Tang China
Yang Jiao China
Yurong Da China
Alka Bhatia India
Faisal Aziz United States
Liangbin Lin relative to Siamak Sandoghchian Shotorbani Iran Siamak Sandoghchian Shotorbani's profile →
Citations per field
00.5×
Siamak Sandoghchian Shotorbani · 1×
Citations per year

Countries citing papers authored by Liangbin Lin

Since Specialization
Citations

This map shows the geographic impact of Liangbin Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liangbin Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liangbin Lin more than expected).

Fields of papers citing papers by Liangbin Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liangbin Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liangbin Lin. The network helps show where Liangbin Lin may publish in the future.

Co-authorship network of co-authors of Liangbin Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Liangbin Lin. A scholar is included among the top collaborators of Liangbin Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liangbin Lin. Liangbin Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 16
2 13
3 1
4 0
5 4
6 4
7 0
8 2
9 11
10
Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical studybreakdown →
1422
11 50
12 116

About Liangbin Lin

Liangbin Lin is a scholar working on Immunology, Cancer Research and Genetics, having authored 12 papers that have together received 1.6k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (4 papers), interferon and immune responses (3 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Immunology (573 citations), Cancer Research (309 citations) and Pharmacology (101 citations). Liangbin Lin has collaborated with scholars based in China, United States and Denmark. Frequent co-authors include Hongbo Hu, Huiyuan Zhang, Hui Yu, Zhiqiang Zhang, Xiang Hu, Yanli Tong, Yanqiu Gong, Lunzhi Dai, Jun Mou and Yantong Liu. Their work appears in journals such as Scientific Reports, Small and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026